http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0180862-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63dfc8b1bce837a93a49230c74be18f4 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 2001-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b950e7a66d55016db64ee6d3eb289b95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc4930e09a00be9f90fcf45ac5f5148 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4952d44fbd259a6546c2056305bfed51 |
| publicationDate | 2001-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-0180862-A1 |
| titleOfInvention | Use of mmp inhibitors in filtering blebs and ischemia |
| abstract | This invention provides a method of inhibiting, preventing, and/or treating conjunctival filtering bleb leaks that may occur following glaucoma filtering surgery by administering Matrix Metalloproteinase inhibitors to glaucoma patients who have undergone such surgery. The invention additionally includes a method of using Matrix Metalloproteinase inhibitors to inhibit, prevent, and/or treat ischemic damage to the retina and optic nerve in patients in need of such treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03074735-A1 |
| priorityDate | 2000-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 306.